Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience-Reference-Cited by-同舟云学术

Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience

Published:2016-11 Issue: Volume:147 Page:32-35
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Arachchillage DRJ,Reynolds R,Devey T,Maclean R,Kitchen S,van Veen JJ

Publisher

Elsevier BV

Subject

Hematology

Reference11 articles.

1. Measuring oral direct inhibitors (ODIs) of thrombin and factor Xa: a recommendation from the subcommittee on control of anticoagulation of the scientific and standardisation committee of the international society on thrombosis and haemostasis;Baglin;J. Thromb. Haemost.,2013

2. (Measurement of non-coumarin anticoagulants and their effects on tests of haemostasis: guidance from the British committee for standards in haematology;Kitchen;Br. J. Haematol.,2014

3. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH;Martin;J. Thromb. Haemost.,2016

4. Fixed-dose rivaroxaban is not associated with increased recurrent venous thromboembolism or major bleeding in patients with a high or low body weight;Prins;J. Thromb. Haemost.,2015

5. Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated partial thromboplastin times using various reagents;Dale;J. Thromb. Haemost.,2014

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real life results of direct-acting oral anticoagulants recommended-dose in obese vs normal-weight patients with venous thromboembolism;Thrombosis Research;2024-01

2. Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications;TH Open;2024-01

3. Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data;European Journal of Clinical Pharmacology;2023-10-10

4. Generic Methods for Simultaneous Analysis of Four Direct Oral Anticoagulants in Human Plasma and Urine by Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry;Molecules;2023-02-28

5. Pharmacokinetics and Dosing Regimens of Direct Oral Anticoagulants in Morbidly Obese Patients: An Updated Literature Review;Clinical and Applied Thrombosis/Hemostasis;2023-01